Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Codexis Inc (CDXS)

Codexis Inc (CDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Codexis: Q2 Earnings Snapshot AP - Tue Aug 11, 3:42PM CDT

Codexis: Q2 Earnings Snapshot

CDXS : 1.5800 (-1.25%)
Codexis Reports Second Quarter 2026 Financial Results GlobeNewswire - Tue Aug 11, 3:05PM CDT

Reports revenue of $14.9 million for the second quarter of 2026, company reiterates full-year financial guidance Shared new advances in RNA therapeutic manufacturing at TIDES US showing that its ECO...

CDXS : 1.5800 (-1.25%)
Codexis Appoints David Butler, PhD, to Strategic Advisory Board GlobeNewswire - Mon Aug 3, 8:00AM CDT

REDWOOD CITY, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics,...

CDXS : 1.5800 (-1.25%)
Codexis to Report Second Quarter 2026 Financial Results on August 11 GlobeNewswire - Tue Jul 28, 8:00AM CDT

REDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 1.5800 (-1.25%)
Codexis Announces Pricing of Public Offering of Common Stock GlobeNewswire - Thu Jul 23, 10:47PM CDT

REDWOOD CITY, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics,...

CDXS : 1.5800 (-1.25%)
Codexis Announces Proposed Public Offering of Common Stock GlobeNewswire - Thu Jul 23, 3:13PM CDT

REDWOOD CITY, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics,...

CDXS : 1.5800 (-1.25%)
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA GlobeNewswire - Wed May 20, 8:00AM CDT

REDWOOD CITY, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Codexis, a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, shared new...

CDXS : 1.5800 (-1.25%)
MarketBeat.com
Codexis Q1 Earnings Call Highlights MarketBeat - Thu May 7, 4:39PM CDT

Codexis (NASDAQ:CDXS) reported first-quarter 2026 revenue of $15.2 million, up from $7.5 million a year earlier, as the company highlighted continued progress commercializing its ECO Synthesis enzymatic...

CDXS : 1.5800 (-1.25%)
Codexis: Q1 Earnings Snapshot AP - Thu May 7, 4:34PM CDT

Codexis: Q1 Earnings Snapshot

CDXS : 1.5800 (-1.25%)
Codexis Reports First Quarter 2026 Financial Results GlobeNewswire - Thu May 7, 3:05PM CDT

Reports revenue of $15.2 million for the first quarter, company reiterates full-year financial guidance Three presentations at upcoming TIDES USA annual meeting to feature new data for ECO Synthesis...

CDXS : 1.5800 (-1.25%)

Barchart Exclusives

Bill Ackman Loves This Dividend Stock, But You Should Give It a Pass Barchart - Thu Aug 20, 6:30PM CDT
Bill Ackman's Pershing Square has held shares of Restaurant Brands International for over a decade. QSR stock has a healthy dividend yield of 3.4% but does not look like a compelling buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.